Search

everythinglearnresearchcommunity

for

Search:↓

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The document talks about common baldness, its features, and potential treatments.

The document suggests that male hormones likely affect hair growth and baldness, and future treatments might involve stem cells and androgen-independent cells.

Certain cultural hair practices might cause baldness by affecting natural hair oils and stem cell delivery to hair follicles.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

The herbal mixture Xiantene may help treat common baldness, and men who grey early tend to be less bald but more grey.

Increased PPARGC1α relates to hair thinning in common baldness.

Inflammation in hair follicles is a key risk factor for developing common baldness.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

The document suggests "anisotrichosis" as a new term for hair thickness variation in common baldness.

New hair loss subtype found, mimics common baldness.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Nepenthes kampotiana extract can potentially prevent hair loss and could be an effective treatment for common baldness.

Ahmad's NPRT system accurately documents and predicts male pattern baldness.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Some patients using Minoxidil for baldness developed allergic skin reactions.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.